-+ 0.00%
-+ 0.00%
-+ 0.00%
ST Tiansheng announced that due to false records of financial indicators in the 2017-2018 annual report, other risk warnings have been implemented since September 15, 2025. At present, the company has completed the retroactive review of the relevant annual financial report. It has been 12 months since the administrative penalty decision was issued. There are no other risk warnings. It has met all the conditions for withdrawing other risk warnings, and has submitted an application for cancellation to the Shenzhen Stock Exchange. The application is still subject to review by the Shenzhen Stock Exchange, and there is uncertainty about whether it will be approved. If approved, the company's stock abbreviation will be changed from “ST Tiansheng” to “Tiansheng Pharmaceutical”, and the stock code will remain unchanged.
Share
Listen to the news
ST Tiansheng announced that due to false records of financial indicators in the 2017-2018 annual report, other risk warnings have been implemented since September 15, 2025. At present, the company has completed the retroactive review of the relevant annual financial report. It has been 12 months since the administrative penalty decision was issued. There are no other risk warnings. It has met all the conditions for withdrawing other risk warnings, and has submitted an application for cancellation to the Shenzhen Stock Exchange. The application is still subject to review by the Shenzhen Stock Exchange, and there is uncertainty about whether it will be approved. If approved, the company's stock abbreviation will be changed from “ST Tiansheng” to “Tiansheng Pharmaceutical”, and the stock code will remain unchanged.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending